Ameriprise’s Array Biopharma Inc ARRY Stock Holding History

Ameriprise’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-538,490	Closed	-$24.9M	–	3832
2019 Q2	$24.9M	Sell	538,490 -246,990	-31%	-$6.93M	0.01%	1016
2019 Q1	$19.1M	Buy	785,480 +533,433	+212%	+$11.1M	0.01%	1176
2018 Q4	$3.59M	Buy	252,047 +9,320	+4%	+$141K	﹤0.01%	2337
2018 Q3	$3.69M	Buy	242,727 +79,732	+49%	+$1.22M	﹤0.01%	2538
2018 Q2	$2.74M	Sell	162,995 -67,331	-29%	-$1.07M	﹤0.01%	2593
2018 Q1	$3.76M	Buy	230,326 +38,184	+20%	+$612K	﹤0.01%	2375
2017 Q4	$2.46M	Buy	192,142 +68,316	+55%	+$777K	﹤0.01%	2563
2017 Q3	$1.52M	Buy	+123,826	New	+$1.15M	﹤0.01%	2752
2014 Q4	–	Sell	-130	Closed	–	–	4738
2014 Q3	$0	Sell	130 -90	-41%	-$355	﹤0.01%	5951
2014 Q2	$1K	Buy	+220	New	+$910	﹤0.01%	5427
2013 Q4	–	Sell	-7,279	Closed	-$45K	–	5544
2013 Q3	$45K	Hold	7,279	–	–	﹤0.01%	3884
2013 Q2	$33K	Buy	+7,279	New	+$39.1K	﹤0.01%	3974

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Ameriprise's ARRY Position: Q3 2019 in Review

Ameriprise sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 538,490 shares — an estimated $24.9M sold.

Ameriprise first reported a position in ARRY in Q2 2013 and held it in 12 quarters. The position peaked at $24.9M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Ameriprise reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Ameriprise sold 538,490 Array Biopharma Inc shares in Q3 2019, an estimated $24.9M.
Ameriprise first reported a position in Array Biopharma Inc in Q2 2013 and held it in 12 quarters.
Ameriprise's Array Biopharma Inc position peaked at $24.9M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Ameriprise's 13F filing for Q3 2019, filed 14 Nov 2019.